Liposomal Ozonated Oil in Ocular Infections: A Review of Preclinical and Clinical Studies, Focusing on Its Antiseptic and Regenerative Properties
- PMID: 35726319
- PMCID: PMC9206455
- DOI: 10.2147/OPTH.S360929
Liposomal Ozonated Oil in Ocular Infections: A Review of Preclinical and Clinical Studies, Focusing on Its Antiseptic and Regenerative Properties
Abstract
Ozonated oil has shown antimicrobial, anti-inflammatory and regenerative properties that make it useful in the prevention of infectious diseases and also as an adjuvant in wound-healing management. This review brings together most aspects of the use of liposomal ozonated oil for ocular infections and regeneration of the ocular surface. A search was performed in PubMed, Medline, Web of Science and Cochrane Library for studies published by June 2021. Search terms were combined to sort out papers on the properties and use of ozonated oil in ocular infections. A total of 25 publications were selected for this review on the composition, mechanism of action, restorative action, and preclinical and clinical studies of liposomal ozonated oil focused on ocular infections. In patients with complicated corneal pathology, liposomal ozonated oil has been found to restore corneal ulcers and improve keratitis. In patients with ocular pathologies involving inflammation and infections, liposomal ozonated oil has been found to improve and almost completely restore the signs of vernal, granulomatous and even adenoviral conjunctivitis. Liposomal ozonated oil has also been found to be effective in reducing ocular microbial flora. In conclusion, liposomal ozonated oil has an antiseptic and regenerative effect on corneoconjunctival tissues. It has demonstrated efficacy and safety profile for its use in ocular infections and can be considered as a suitable supportive strategy both alone and combined with other antimicrobial agents.
Keywords: antifungal; antimicrobial; antiviral; liposomal ozonated oil; restorative action.
© 2022 Pérez-Santonja et al.
Conflict of interest statement
Dr Pérez-Santonja is a consultant for Esteve Pharmaceuticals. Dr Güell is a consultant for Opthec, Meditec, Zeiss, Alcon, Thea Laboratories, Kowa Pharmaceuticals and RxSight. Dr Vázquez is a consultant for Esteve Pharmaceuticals and Visufarma. Dr Benitez-Del-Castillo is a consultant for Allergan Angelini, Esteve Pharmaceuticals, GSK, Lumenis, Novartis, Santen, Sifi, Thea Laboratories and Visufarma. The authors report no other conflicts of interest in this work.
Figures
References
-
- Martínez-Sánchez G. Ozonized water, background, general use in medicine and preclinic support. Ozone Ther Global J. 2019;9(1):33–60.
-
- Cutarelli A, Carlini G, Sarno F, et al. The role of ozone carried by liposomes in the therapy of infectious and skin-regenerating ocular surface. J Biomed Sci Eng. 2019;12(7):347–353. doi:10.4236/jbise.2019.127026 - DOI
-
- Martínez- Sánchez G, Re L, Perez-Davison G, Delaporte RH. Medical uses of ozonized oils, an up-date. Revista Española de Ozonoterapia. 2012;2(1):121–139.
Publication types
LinkOut - more resources
Full Text Sources
